These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31004601)

  • 1. Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes.
    Xie W; Wang SA; Yin CC; Xu J; Li S; Bueso-Ramos CE; Medeiros LJ; Tang G
    Exp Mol Pathol; 2019 Jun; 108():131-136. PubMed ID: 31004601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia.
    Kristensen T; Preiss B; Broesby-Olsen S; Vestergaard H; Friis L; Møller MB
    Leuk Lymphoma; 2012 Jul; 53(7):1338-44. PubMed ID: 22145956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients.
    Won D; Chi HS; Shim H; Jang S; Park CJ; Lee JH
    Leuk Res; 2013 Aug; 37(8):883-8. PubMed ID: 23683787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1.
    Pullarkat ST; Pullarkat V; Lagoo A; Brynes R; Weiss LM; Bedell V; Chen W; Huang Q; Gaal K; Weisenburger DD; Kim YS
    Leuk Res; 2013 Nov; 37(11):1572-5. PubMed ID: 24035334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone.
    Pullarkat V; Bedell V; Kim Y; Bhatia R; Nakamura R; Forman S; Sun J; Senitzer D; Slovak ML
    Leuk Res; 2007 Feb; 31(2):261-5. PubMed ID: 16876862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic mastocytosis associated with t(8;21) acute myeloid leukemia in a child: detection of the D816A mutation of KIT.
    Yabe M; Masukawa A; Kato S; Yabe H; Nakamura N; Matsushita H
    Pediatr Blood Cancer; 2012 Dec; 59(7):1313-6. PubMed ID: 22847983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidden mastocytosis in acute myeloid leukemia with t(8;21)(q22;q22).
    Johnson RC; Savage NM; Chiang T; Gotlib JR; Cherry AM; Arber DA; George TI
    Am J Clin Pathol; 2013 Oct; 140(4):525-35. PubMed ID: 24045550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical Staining to Identify Concomitant Systemic Mastocytosis in Acute Myeloid Leukemia with
    Hwang SM; Kim BJ; Lee JS; Seong MW; Seo SH; Paik JH; Kim SA; Lee JY; Lee JO; Chang YH; Bang SM
    Ann Lab Med; 2022 Nov; 42(6):678-682. PubMed ID: 35765876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation into acute myeloid leukemia with t(8;21)(q22;q22.1); RUNX1::RUNX1T1 from JAK2-mutated essential thrombocythemia: a case report.
    Asou C; Sakamoto T; Suzuki K; Okuda I; Osaki A; Abe R; Ito Y; Kakegawa E; Miyakawa Y; Terui Y; Nakamura Y
    J Med Case Rep; 2024 Aug; 18(1):372. PubMed ID: 39154170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1.
    Liu H; Wang SA; Schlette EJ; Xu J; Jorgensen JL; Cameron Yin C; Li S; Jeffrey Medeiros L; Tang G
    Ann Hematol; 2018 Oct; 97(10):1775-1783. PubMed ID: 29872884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
    Kim HJ; Ahn HK; Jung CW; Moon JH; Park CH; Lee KO; Kim SH; Kim YK; Kim HJ; Sohn SK; Kim SH; Lee WS; Kim KH; Mun YC; Kim H; Park J; Min WS; Kim HJ; Kim DH;
    Ann Hematol; 2013 Jan; 92(2):163-71. PubMed ID: 23053179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of systemic mastocytosis with RUNX1-RUNX1T1 positive acute myeloid leukemia treated with sequential avapritinib after allogeneic hematopoietic stem cell transplantation and literature review].
    Wang J; Zu YL; Gui RR; Li Z; Zhang Y; Zhou J
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):505-508. PubMed ID: 38964927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)].
    Wada A; Doki N; Otsuka Y; Adachi H; Konuma R; Kishida Y; Konishi T; Yamada Y; Nagata A; Nagata R; Marumo A; Noguchi Y; Mukae J; Toya T; Igarashi A; Najima Y; Kobayashi T; Harada H; Harada Y; Sakamaki H; Ohashi K
    Rinsho Ketsueki; 2022; 63(2):104-107. PubMed ID: 35264498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.
    Srinivasan S; Dhamne C; Patkar N; Chatterjee G; Moulik NR; Chichra A; Pallath A; Tembhare P; Shetty D; Subramanian PG; Narula G; Banavali S
    Pediatr Blood Cancer; 2024 Feb; 71(2):e30791. PubMed ID: 38014874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the therapeutic effect of avatinib bridged allogeneic hematopoietic stem cell transplantation on 7 cases of recurrent/refractory RUNX1-RUNX1T1 positive acute myeloid leukemia with KIT mutations].
    Han SY; Zhou HX; Han Y; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2024 Aug; 45(8):767-771. PubMed ID: 39307724
    [No Abstract]   [Full Text] [Related]  

  • 16. A Novel KIT INDEL Mutation in Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1.
    Lee JH; Park C; Kim SH; Shin MG
    Ann Lab Med; 2016 Jul; 36(4):371-4. PubMed ID: 27139612
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
    Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
    Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Four-Way t(8;14;15;21)(q22;q22;q15;q22.1) Translocation Variant in Acute Myeloid Leukemia with
    Tsuge N; Ogasawara F; Kondo T; Yoshida S; Kojima K
    Turk J Haematol; 2024 May; 41(2):128-129. PubMed ID: 38488305
    [No Abstract]   [Full Text] [Related]  

  • 19. Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases.
    Wang Q; Hu Y; Gao L; Zhang S; Lu J; Li B; Li J; Yao Y; Cheng S; Xiao P; Hu S
    Ann Hematol; 2024 Sep; 103(9):3795-3800. PubMed ID: 38802593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. t(2;2;21;8)(p21;q37;q22;q22), a novel four-way complex translocation involving variant t(8;21) in case of acute myeloid leukemia : A case report and literature review.
    Han B; Jing Y; Bi X; Lin Y; Li H; Li H; Ru K; Yang S
    Cancer Genet; 2024 Jun; 284-285():1-4. PubMed ID: 38460349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.